Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
- PMID: 34079770
- PMCID: PMC8165386
- DOI: 10.3389/fcimb.2021.684515
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
Abstract
Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as "antibiotic adjuvants" to enhance the activity of certain antibiotics.
Keywords: antibiotics; drug development; drug repurposing; reverse translation; translational science.
Copyright © 2021 Boyd, Teng and Frei.
Conflict of interest statement
CF’s institutions have received grant money, for CF to perform research, from AstraZeneca Pharmaceuticals, in the last 3 years. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD012252. doi: 10.1002/14651858.CD012252.pub2. Cochrane Database Syst Rev. 2017. PMID: 28881002 Free PMC article.
-
FDA-approved drugs for targeting virulence of Pseudomonas aeruginosa: A drug repurposing approach to combat multidrug resistance.Microb Pathog. 2025 Sep;206:107781. doi: 10.1016/j.micpath.2025.107781. Epub 2025 Jun 3. Microb Pathog. 2025. PMID: 40473130 Review.
-
Idiopathic (Genetic) Generalized Epilepsy.2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31536218 Free Books & Documents.
Cited by
-
Uncovering the potentiality of quinazoline derivatives against Pseudomonas aeruginosa with antimicrobial synergy and SAR analysis.J Antibiot (Tokyo). 2024 Jun;77(6):365-381. doi: 10.1038/s41429-024-00717-3. Epub 2024 Mar 21. J Antibiot (Tokyo). 2024. PMID: 38514856
-
Wastewater treatment plants, an "escape gate" for ESCAPE pathogens.Front Microbiol. 2023 May 24;14:1193907. doi: 10.3389/fmicb.2023.1193907. eCollection 2023. Front Microbiol. 2023. PMID: 37293232 Free PMC article. Review.
-
Back to Nature: Medicinal Plants as Promising Sources for Antibacterial Drugs in the Post-Antibiotic Era.Plants (Basel). 2023 Aug 28;12(17):3077. doi: 10.3390/plants12173077. Plants (Basel). 2023. PMID: 37687324 Free PMC article. Review.
-
Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics.Infect Dis Ther. 2022 Aug;11(4):1315-1326. doi: 10.1007/s40121-022-00656-2. Epub 2022 May 23. Infect Dis Ther. 2022. PMID: 35608734 Free PMC article.
-
The dawn of repurposing vitamins as potential novel antimicrobial agents: A call for global emergency response amidst AMR crisis.Health Sci Rep. 2023 May 20;6(5):e1276. doi: 10.1002/hsr2.1276. eCollection 2023 May. Health Sci Rep. 2023. PMID: 37216052 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical